Kidney Cancer
AVEO Oncology Rejoices FDA Approval for TKI, Finds Able Partner in BMS to Trial Combo Therapy for Kidney Cancer
2021-03-13
Merck, Eisai’s Combo Therapy Registers Superiority against Pfizer’s Drug in Kidney Cancer Trial
2020-11-15
LATEST
Study Finds Treatment Variations in Immunobullous Disorders Linked to Demographic Factors
2026-01-24
Study Finds Orexin Receptor Agonists May Pose Higher Fracture Risk Compared to Melatonin Receptor Agonists
2026-01-24
Researchers Develop Distributed Method Using Control Barrier Functions to Enhance Network Connectivity
2026-01-24



